We Are One Seven LLC bought a new stake in shares of MetLife (NYSE:MET) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 13,694 shares of the financial services provider’s stock, valued at approximately $692,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Cowen Prime Services LLC boosted its position in MetLife by 16.0% during the 3rd quarter. Cowen Prime Services LLC now owns 7,250 shares of the financial services provider’s stock valued at $377,000 after acquiring an additional 1,000 shares in the last quarter. Investment Centers of America Inc. boosted its position in MetLife by 11.6% during the 3rd quarter. Investment Centers of America Inc. now owns 9,874 shares of the financial services provider’s stock valued at $511,000 after acquiring an additional 1,026 shares in the last quarter. Zions Bancorporation boosted its position in MetLife by 15.9% during the 3rd quarter. Zions Bancorporation now owns 7,599 shares of the financial services provider’s stock valued at $395,000 after acquiring an additional 1,045 shares in the last quarter. CLS Investments LLC boosted its position in MetLife by 18.7% during the 3rd quarter. CLS Investments LLC now owns 6,792 shares of the financial services provider’s stock valued at $353,000 after acquiring an additional 1,072 shares in the last quarter. Finally, Jolley Asset Management LLC boosted its position in MetLife by 1.4% during the 4th quarter. Jolley Asset Management LLC now owns 76,446 shares of the financial services provider’s stock valued at $3,865,000 after acquiring an additional 1,085 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Shares of MetLife stock opened at $46.89 on Thursday. MetLife has a 52-week low of $43.38 and a 52-week high of $55.91. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.15. The firm has a market capitalization of $48,929.55, a price-to-earnings ratio of 9.52, a PEG ratio of 0.96 and a beta of 1.28.
MetLife (NYSE:MET) last issued its quarterly earnings results on Tuesday, February 13th. The financial services provider reported $0.64 EPS for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.41). MetLife had a return on equity of 8.59% and a net margin of 5.69%. The firm had revenue of $15.79 billion for the quarter, compared to analyst estimates of $15.89 billion. During the same period in the prior year, the firm posted $1.28 EPS. research analysts expect that MetLife will post 4.93 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th were given a dividend of $0.40 per share. The ex-dividend date was Friday, February 2nd. This represents a $1.60 dividend on an annualized basis and a yield of 3.41%. MetLife’s dividend payout ratio is currently 46.92%.
Several analysts have issued reports on the company. Zacks Investment Research cut MetLife from a “hold” rating to a “sell” rating in a research report on Tuesday. Wells Fargo reaffirmed a “buy” rating and set a $60.00 target price on shares of MetLife in a research report on Friday, March 16th. ValuEngine raised MetLife from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, March 7th. UBS reaffirmed a “neutral” rating and set a $51.00 target price (down previously from $52.00) on shares of MetLife in a research report on Friday, March 2nd. Finally, Keefe, Bruyette & Woods reissued a “buy” rating and issued a $56.00 price objective on shares of MetLife in a research report on Friday, February 23rd. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $57.90.
WARNING: “We Are One Seven LLC Takes Position in MetLife (MET)” was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/03/22/we-are-one-seven-llc-takes-position-in-metlife-met.html.
MetLife Company Profile
MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife (NYSE:MET).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.